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Abstract
Background: The concept of quality of life relates to the perceptions of individuals about their mental and
physical health as well as non-health related areas. The evaluation of quality of life in the context of substance
abuse has been conducted using generic instruments. The Drug Users Quality of Life Scale (DUQOL) is a specific
assessment tool in which the most pertinent and salient areas to drug abusers are taken into consideration. In this
study, the authors report the results of a validation study in which the DUQOL was used for the first time in
Australia.
Methods: A sample of 120 participants from inpatient and outpatient treatment facilities completed a series of
questionnaires, including the DUQOL and the World Health Organization Quality of Life Assessment-BREF
(WHOQOL-BREF). Parameters investigated in this study included the demographic characteristics of the sample,
internal structure, and convergent validity. Correlations between the DUQOL scale scores and the scores of the
WHOQOL-Bref test were investigated via Pearson product-moment correlation analyses.
Results: The English version of the DUQOL attained a significant overall Cronbach’s alpha of 0.868. The factorial
analysis of the DUQOL identified one principal factor that accounted for 28.499% of the variance. Convergent
validity analyses demonstrate significant correlations (p < 0.01) between the DUQOL scores and the scores of all
four dimensions of the WHOQOL-BREF questionnaire.
Conclusions: This study demonstrates that the DUQOL constitutes a reliable research instrument for evaluating
quality of life of substance users in Australia.
Keywords: Quality of life, Questionnaires, Substance-related disorders, Validation studies, Australia
Introduction
The field of quality of life (QoL) measurement has been
evolving as a formal discipline with structured theoretical
foundations and a specific methodology for over 30 years
[1]. Quality of life has become increasingly recognized as
an important outcome measure in treatment studies and
health service research [2]. The evaluation of QoL is also
widely used in clinical trials and in observational studies
of health and disease with the aim of evaluating interven-
t i o n sa sw e l la sa d v e r s ee f f e c t so ft r e a t m e n ta n dt h e
impact of the disease process itself [3].
According to the World Health Organization (WHO),
health can be defined as a state of complete physical,
mental and social well-being [4]. Yet, the conceptual
boundaries of QoL has been re-examined in order to
include additional elements such as sociocultural condi-
tions, as well as factors contributing to mental and physi-
cal health, which ideally will transcend the rather
circumscribed dichotomy of the health-disease process [5].
Gill and Feinstein [6] defined QoL as a reflection of
respondents’ perceptions and reactions to not only their
mental and physical health, but also to non-health-related
areas, including family, friends and work. A broader defini-
tion also includes life satisfaction, attainment in social and
professional roles, a sense of being productive, a sense of
control over one’s destiny, as well as a pleasurable and
satisfying sense of existence and spiritual fulfillment [7].
Other definitions give salience to factors related to
patients’ health status and overall functioning, including
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any medium, provided the original work is properly cited.absence of symptoms, physical aptitude, emotional aspects,
cognitive capacity and overall sense of life-satisfaction [8].
Quality of life instruments have been distinguished as
generic or specific tools [9]. The generic instruments are
so-called due to the lack of a specific correlation with any
particular disease process. Generic QoL measures cover a
broad spectrum of dimensions related to QoL, including
physical aptitude, social relationships, mental well-being
and an overall perception of physical and general QoL.
These questionnaires were conceived for use both in
samples from the general population and from specific
groups of patients with the goal of evaluating various dis-
eases and the impact of their treatment [10]. The specific
tools, on the other hand, were developed to evaluate the
difficulties presented in a specific group of patients or
associated with a specific disorder.
Quality of life is also becoming an important clinical
and research outcome within the drug and alcohol abuse
context. The subjective aspect of QoL, especially in the
field of mental health, has achieved importance in the
measurement of therapeutic results, which facilitated a
gradual shift in clinical focus from identifying a cure to
enhancing QoL [11]. Taking into account the usual
chronic nature of substance dependence, it is important
to establish a model of longitudinal monitoring, which
helps to improve communication between patients and
healthcare professionals [12].
In the area of substance abuse, the concept of QoL has
been applied to evaluate functioning, well-being and life
satisfaction [13,14]. Ideally, the objective of evaluating
QoL among drug-dependent individuals should be not
only to evaluate patients with regard to the presence or
absence of symptoms or adverse reaction to treatment,
but also to focus on how drug-dependent individuals
experience their daily lives [15,16]. In the area of sub-
stance use, though, the evaluation of QoL of substance
users has been conducted mainly using generic QoL
instruments [17]. Some studies have focused preferen-
tially on health-related factors, which overshadows the
complexities of drug dependence or personal factors that
may hinder effective treatment [15]. A recent generation
of assessment tools is currently focusing on areas specifi-
cally related to substance use. In contrast to general QoL
measures, which are structured around domains of simi-
lar importance, QoL tools specifically designed for sub-
stance use measurement allow for a specific selection of
life areas that are most salient for drug users (DUs)[18].
The Injection Drug User Quality of Life Scale (IDU-
QOL) is a specific QoL assessment tool designed in
Canada, which evaluates health and non-health related
aspects of the injecting drug users, with an emphasis on
individual circumstances and environmental factors. Many
of the areas included in the IDUQOL “are particularly
relevant to the physical, social, psychological, occupational,
and geographical reality” of substance users. [[19], pg.3].
The psychometric properties of a preliminary 17-item
English version of the Injection Drug User Quality of Life
Scale (IDUQOL) were assessed in a sample of 61 partici-
pants [20]. Later, a validation study of a 21-item English
version revealed that the IDUQOL total score measures a
construct consistent with quality of life [19]. The 21-item
version was adapted to Spanish and its psychometric prop-
erties were evaluated in a sample of 100 participants in
Spain [21]. Subsequently, a 22-item English version was
developed to further “evaluate overall quality of life in
DUs in a particular region”[22]. The 22-item version,
denominated Drug User Quality of Life Scale (DUQOL),
was adapted and translated to Spanish for the assessment
of users of both injectable and non-injectable drugs in
Spain [23]. The Spanish version was considered a valid
measure of subjective QoL among drug users, which can
be used to assess changes in QoL as a result of interven-
tions such as harm reduction strategies, health care ser-
vices, housing initiatives, and drug treatment programs
[23]. The current study was developed with the aim of
assessing the psychometrics properties of the English ver-
sion of the DUQOL (22 items) as used for the first time in
Australia. To the authors’ knowledge, this is the first time
that the 22-item English version of this instrument is
tested in a sample of treatment-seeking individuals.
Methods
Sample
This study evaluated 120 adults recruited from inpatient
and outpatient treatment facilities within the Western
Sydney Local Health District catchment area, Australia,
from April to October 2010. Research sites included
Blacktown Hospital, Cumberland Hospital, Nepean Hos-
pital, and the Mount Druitt Centre for Addiction Medi-
cine, all of which are higher education training facilities
within Western Sydney Local Health District. Potential
participants presenting for treatment were randomly
invited to respond to the questionnaires. The inclusion
criteria comprised (a) being above the age of 18; (b) ful-
fillment of the DSM-IV (Diagnostic and Statistical Man-
ual of Mental Disorders, 4th Edition) criteria for any
disorder related to substance use and (c) the ability to
understand the aim of the study as well as the content of
the questions in both questionnaires, which entailed a
satisfactory command of English. Exclusion criteria com-
prised of presentations exclusively due to alcohol abuse
and/or involuntary admission for inpatient treatment.
Informed consent
This study was granted approval by the Western Sydney
Local Health District Human Research Ethics Commit-
tee. Prospective participants were provided with a written
protocol pertaining to the study and a verbal explanation
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that participation was voluntary, confidential and anon-
ymous. Volunteers were also informed that they could
withdraw from this study at any time without any reper-
cussion to their treatments. Research participants were
then asked to sign an informed consent form prior to
their inclusion in the study.
Interview process
Five data collectors underwent a period of training and
supervision by the principal investigator prior to adminis-
tering questionnaires independently. The data collectors
met regularly to address any queries and ensure each were
following the same procedure. The study participants
completed the questionnaires under minimal guidance
from the trained examiners, who followed standardized
instructional procedures. Interviews took place in a suita-
ble room at one of the research sites mentioned above.
Occasionally, specific questions not considered in the
initial instruction procedures were answered on a one-to-
one basis. Particular care was taken with non-native
English speaking participants in order to ensure a satisfac-
tory understanding.
Instruments
The drug users quality of life scale (DUQOL)
The DUQOL assesses an individual’s QoL and satisfac-
tion in 22 life domains. It is constituted of 7-point Likert
scales, which range from 1 (very unsatisfied) to 7 (very
satisfied) resulting an average total score of QoL, an aver-
age total score for important areas and an average total
score for areas that are not important. Volunteers are
asked to classify each life area as “important” or “unim-
portant” to them. Each life domain is portrayed on a 5 by
5 inch card, with the name of the domain, a representa-
tive picture on the front of the card, and a description of
the domain on the back of the card. The sum of the 22
scores generates a mean overall quality of life score, such
that the higher the score, the better the quality of life.
The mean overall QoL score is expressed quantitatively
and without cut-off thresholds. In this study, the English
version of the DUQOL was used [22].
The world health organization quality of life assessment-
BREF (WHOQOL-BREF)
The World Health Organization Quality of Life Assess-
ment-BREF (WHOQOL-BREF), is a questionnaire devel-
oped by the WHO as an abbreviated 26-item version of
the WHOQOL-100 instrument for the assessment of qual-
ity of life across various cultural settings [24]. The WHO-
QOL-BREF is divided into four domains: Physical,
Psychological, Social Relationships, and Environment.
Each domain score reflects an individual’s perception of
his or her quality of life in that particular area. Two
additional questions examine the individual’s overall per-
ception of (1) quality of life and (2) health status. The
WHOQOL-BREF has been validated across a wide range
of languages.
In addition to the DUQOL and WHOQOL-BREF,
research participants were also asked to complete forms
related to demographic information including age, sex,
ethnicity, highest level of educational attainment,
employment status, and most frequently consumed
drugs.
Databank configuration
One patient did not complete the DUQOL questionnaire
due to emergence of symptoms of restlessness during the
interview. Three volunteers did not complete a subset of
questions related to “important and non-important” life
areas. Two research participants did not complete the
two final questions of the DUQOL questionnaire, in
which cases the mean scores of the first 20 questions
were used as a proxy value. All remaining DUQOL and
WHOQOL-BREF questionnaires were completed prop-
erly and therefore given full statistical consideration.
Statistical analysis
Descriptive statistics were used to analyze demographic
information. The analysis of internal consistency of the
English version of the DUQOL tested in Australia was
determined by generating Cronbach’s alpha indices for
each question of this assessment tool. The factorial ana-
lysis of the same scale was conducted by Maximum
Likelihood Factor analysis with Varimax rotation. Appli-
cation of the scree test was performed to identify the
most meaningful factorial structure.
A series of correlations between the DUQOL scale
scores and the scores of each dimension of the WHO-
QOL-Bref test were investigated via Pearson product-
moment correlation analyses. All analyses were con-
ducted with IBM SPSS Statistics
® software.
Results
Demographic information
The sample consisted of 76 males (63.3%) and 44
females (36.7%). The mean age of the sample was 37.68
years (SD = 10.41), and there was no significant age dif-
ference between male and female participants. In terms
of educational attainment, 66.1% had not completed sec-
ondary school, 18.2% had completed secondary school,
12.4% had completed vocational studies, and 3.3% had
completed a university degree or higher. In terms of
occupational status, 43% of the sample was employed at
the time of the study, 38% were unemployed, 4.1% were
studying, and 14.9% did not disclose their employment
status.
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Reliability data
The internal consistency (correlation of the items with the
total score) of the English version of the DUQOL is shown
in Table 1. All items included in the DUQOL attained sig-
nificant Cronbach’s alpha of 0.853 or superior. The
DUQOL overall Cronbach’s alpha totaled 0.868. Table 2
presents the inter-item correlation matrix for the
DUQOL, with correlations between all areas and total
score. The correlation scores ranged from 0.241 to 0.778
and the mean of the scores was 0.491.
Factorial analysis
Maximum likelihood factor analysis with Varimax rotation
was conducted on the ratings given by the 120 respon-
dents to the 22-item DUQOL. An initial exploratory factor
analysis yielded six factors with eigenvalues exceeding
unity, which accounted for 59.693% of the variance. As
demonstrated in Figure 1, application of the scree test sug-
gested that a single factor seemed warranted. The one fac-
tor solution appeared the most tenable option, given that
factor one contributed with 28.499% of the variance.
Convergent validity
The results of correlation analyses revealed statistically
significant correlation coefficients between the average
total DUQOL quality of life score and the scores of dif-
ferent dimensions of the WHOQOL-Bref questionnaire.
The magnitude of the correlations are as follows: r =
0.56, p < 0.01 (DUQOL × Physical Domain - D1); r =
0.59, p < 0.01 (DUQOL × Psychological Domain - D2); r
= 0.62, p < 0.01 (DUQOL × Social Domain - D3); and r =
0.69; p < 0.01 (DUQOL × Environmental Domain - D4).
Substance use
The sample used an average of 2.1 different drugs (SD =
1.1). The most frequently used drugs were cannabis
(55.4%), opioids (45.5%), and alcohol (30.6%). Other
common drugs of choice were methamphetamine
("speed”) (28.1%), cocaine (11.6%), benzodiazepines
(used illicitly) (10.6%), ecstasy (8.3%), and other amphe-
tamines (6.6%).
Quality of life - average total score
The mean overall score according to the DUQOL scale
in this sample (n = 120) was 98.3 (SD = 23.5). The
scores ranged from 49 to 151, which indicate that the
application of the DUQOL scale to this population
group achieved neither a ground nor a ceiling effect.
Figure 2 shows the grouped distribution of the average
total quality of life scores.
Table 1 The English version of the Drug User Quality of Life Scale Scale Item Analysis and Reliability Data (n = 120)
Response percentages
Item 1 2 3 4 5 6 7 Mean Standard Deviation Cronbach’s Alpha if Item Deleted
1. Being useful 20 5 6.7 17.5 11.7 12.5 26.7 4.40 2.23 0.863
2. Drugs 31.7 11.7 6.7 20 5 3.3 21.7 3.52 2.31 0.874
3. Drug treatment 7.5 1.7 3.3 22.5 9.2 18.3 37.5 5.29 1.82 0.865
4. Education 16.7 10.8 6.7 25 9.2 12.5 19.2 4.13 2.08 0.867
5. Family 14.2 10 7.5 11.7 10 12.5 34.2 4.67 2.24 0.862
6. Feeling Good 22.5 12.5 7.5 15 16.7 12.5 13.3 3.82 2.11 0.853
7. Friends 16.7 5.8 14.2 17.5 11.7 12.5 21.7 4.26 2.10 0.861
8. Harm reduction 0.8 10.8 3.3 0.8 25 5 9.2 5.15 2.10 0.867
9. Health 20 12.5 7.5 17.5 11.7 15.8 15 3.96 2.12 0.858
10. Health care 5 6.7 6.7 15 8.3 16.7 41.7 5.32 1.89 0.863
11. Housing 18.3 2.5 3.3 9.2 7.5 17.5 41.7 5.04 2.29 0.863
12. Free choice 5 7.5 5.8 20.8 11.7 18.3 30.8 5.05 1.83 0.858
13. Leisure activities 20.8 10.8 10.8 13.3 12.5 15 16.7 3.98 2.16 0.859
14. Money 29.2 13.3 12.5 17.5 7.5 8.3 11.7 3.33 2.08 0.864
15. Neighborhood safety 14.2 7.5 3.3 15 10.8 19.2 30 4.78 2.15 0.864
16. Partner(s) 20 6.7 3.3 37.5 2.5 6.7 23.3 4.09 2.12 0.865
17. Community resources 5 5 3.3 25 17.5 23.3 20.8 4.98 1.65 0.863
18. Sex 25.8 5.8 0.8 33.3 5.8 8.3 20 3.93 2.19 0.866
19. Spirituality 12.5 2.5 1.7 29.2 10 11.7 32.5 4.87 2.00 0.865
20. Transportation 12.5 7.5 8.3 15.8 10.8 17.5 27.5 4.67 2.09 0.866
21. Sense of future 12.5 7.5 12.5 19.2 11.7 15 21.7 4.42 2.02 0.857
22. How other treat you 8.3 9.2 8.3 20 7.5 27.5 19.2 4.68 1.91 0.856
*Rating scale: 1 = Very dissatisfied; 2 = Moderately dissatisfied; 3 = Slightly dissatisfied; 4 = neutral (neither dissatisfied nor satisfied); 5 = slightly satisfied, 6 =
moderately satisfied, and 7 = very satisfied.
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1 2 3 4 5 6 7 8 9 1 01 11 21 31 41 51 61 71 81 92 02 12 2
1 1
2 0.04 1
3 0.076 0.104 1
4 0.195* 0.069 0.144 1
5 0.195* 0.150 0.284 ** 0.136 1
6 0.537** 0.193* 0.301 ** 0.248 ** 0.479 ** 1
7 0.308** 0.097 0.169 0.128 0.265 ** 0.427** 1
8 0.123 0.179* 0.244** 0.093 0.203* 0.216* 0.096 1
9 0.396** 0.159 0.205* 0.167 0.301 ** 0.732** 0.244** 0.206* 1
10 0.205* 0.060 0.297** 0.241** 0.151 0.313** 0.193* 0.203* 0.348** 1
11 0.177 -0.041 0.121 0.226* 0.340** 0.279** 0.205* 0.113 0.343** 0.210* 1
12 0.244** 0.133 0.239** 0.302** 0.287** 0.499** 0.272** 0.279** 0.402** 0.218* 0.303** 1
13 0.400** 0.055 0.117 0.184* 0.288** 0.519** 0.392** -0.007 0.294** 0.164 0.257** 0.424** 1
14 0.289** -0.044 0.192* 0.153 0.014 0.333** 0.175 0.135 0.245** 0.132 0.270** 0.349** 0.396** 1
15 0.159 0.123 0.123 0.112 0.151 0.311** 0.342** 0.130 0.313** 0.164 0.418** 0.257** 0.196* 0.221* 1
16 0.083 006 0.123 0.090 0.386** 0.265** 0.373** 0.265** 0.235** 0.141 0.244** 0.294** 0225* 0.094 0.100 1
17 0.157 0.095 0.292** 0.211* 0.124 0.291** 0.219* 0.194* 0.201 0.478** 0.238** 0.334** 0.254** 0.202* 0.296** 0.041 1
18 0.189* 0.059 0.077 0.008 0.300** 0.258** 0.436** 0.192* 0.173 0.154 0.024 0.179 0.339** 0.173 0.059 0.480** -0.024 1
19 0.170 0.137 0.149 0.242** 0.189 0.282** 0.162 0.094 0.232* 0.317** 0.195* 0.276** 0.338** 0.234** 0.202* 0036. 0.187* 0.103 1
20 0.228* -0.137 0.269** 0.247** 0.099 0.176 0.220* 0.059 0.092 0.169 0.329** 0.351** 0.240** 0.326** 0.332** 0.088 0.332** 0.103 0.032 1
21 0.398** 0.067 0.352** 0.267** 0.330** 0.583** 0.258** 0.252** 0.449** 0.286** 0.297** 0.326** 0.466** 0.410** 0.114 0.234* 0.275** 0.260** 0423** 0.209* 1
22 0.262** 0.277** 0.366** 0.129 0.392** 0.594** 0.478** 0.337** 0.485** 0.353** 0.353** 0.405** 0.321** 0.182* 0.441** 0.340** 0.336** 0.281** 0261** 0.199* 0.413** 1
T 0.515** 0.241** 0.446** 0.400** 0.540** 0.778** 0.570** 0.402** 0.636** 0.495** 0.524** 0.640** 0.480** 0.490** 0.451** 0.483** 0.432** 0.458** 0.430** 0.671** 0.716**
* Correlation is significant at 0.05 level (2-tailed)
** Correlation is significant at 0.01 level (2-tailed)
Items: 1 = Health; 2 = Drugs and Alcohol; 3 = Drug and Alcohol Treatment; 4 = Education and Training; 5 = Family; 6 = Feeling Good About Yourself; 7 = Friends; 8 = Harm Reduction; 9 = Being Useful; 10 = Health
Care; 11 = Housing;
12 = How Others Treat You; 13 = Free Choice; 14 = Leisure Activities; 15 = Money; 16 = Neighborhood safety; 17 = Partner(s); 18 = Community resources; 19 = Sex; 20 = Sense of future; 21 = Spirituality; 22 =
Transportation; T = Total Score.
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9Quality of life - overall self-rating
The overall self-rating of quality of life varied from “very
satisfied” (1.7% of the sample) to “slightly satisfied”
(38.3%). Mid-range percentages were as follows: “moder-
ately dissatisfied” (2.5%); “slightly dissatisfied” (20%); “neu-
tral” (22.5%); and “moderately satisfied” (15%). Figure 3
presents graphically the results mentioned above.
Quality of life - salience of specific life areas
The two areas most frequently considered “important”
for participants’ quality of life was family (91.5%) and
health (82.9%). The areas least frequently considered
important were drug use (16.2%), community resources
(34.2%), and harm reduction (35.0%). Figure 4 shows the
percentage of participants who regarded each life area
as important to their quality of life.
Ease of completion
The majority of research participants found it easy to
complete the DUQOL scale. In this sample, 55.8% of
the sample rated the completion process as “Not diffi-
cult at all”, 25% found it “A little difficult”, 14.4% found
it “Moderately difficult”, and 4.8% reported it as “Extre-
mely difficult”. The mean time taken to complete the
DUQOL scale was 9.24 (SD = 3.88) minutes.
Discussion
Overall, the results of this study provide evidence for the
reliability, validity and usefulness of the Drug User Quality
of Life Scale (DUQOL) as a practical instrument for asses-
sing quality of life in drug users. In this context, reliability
refers to the consistency of a set of measurements or a
25%
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Figure 2 The distribution of the DUQOL total scores in the
sample (n = 120).
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Figure 3 The percentage of participants according to the
overall level of satisfaction with their quality of life.
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Figure 1 Scree plot of the eigenvalues.
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specific life area as important to their quality of life.
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Page 6 of 9measuring instrument, whereas validity refers to he extent
to which a measurement is well-founded and corresponds
accurately to the real world, measuring what it claims to
measure [25]. This is especially relevant given that the
availability of research tools specifically designed to assess
quality of life among substance users is currently limited
[18]. The methodology executed in this study followed the
approach used in additional validation studies of other
psychometric tools conducted by the same research group
[26,27].
In regard to demographic information, approximately
two thirds of the sample comprised of males (63.3%) and
the gender distribution observed in this study, on the
whole, matches the prevalence rates of substance use by
gender in Australia [28]. A prototypical description of
this sample would be a man in his late 30s who has com-
pleted secondary school, possibly employed and seeking
treatment. There has been well-documented evidence
that “cannabis remains the most commonly used illicit
drug in Australia” [28] and that “a need for increased
treatment provision is likely to be largely driven by an
ageing cohort of cannabis users, with daily smoking of
cannabis now most commonly reported among 30-39
year olds” [28]. In addition, the literature indicates that
the majority of those who seek treatment for problems
related to cannabis as their principal drug of concern had
difficulties with another substance [29]. Therefore, in
light of the foregoing, the demographic data and drug
use findings obtained in the current study are consistent
with previous epidemiological evidence collected in
Australia.
The English version of the DUQOL proved to have
sound psychometric properties. Internal consistency data
revealed significant Cronbach’s alpha coefficients for all
22 areas of the DUQOL. The internal consistency of the
English version of the DUQOL demonstrates that the
instrument coherently investigates the construct of qual-
ity of life as measured uniformly by its items. The relia-
bility analysis of data generated in this research was
conducted according to parameters described in similar
studies developed by other investigators [26,27].
The results of the DUQOL factorial analysis demon-
strated that the English version of the DUQOL tested in
this study is structurally unidimensional. Although six
factors were extracted in an exploratory factor analysis,
the scree test revealed one main factor. Different criteria
have been proposed for establishing the number of fac-
tors to extract based on the magnitudes of the eigenva-
lues. On criterion is to retain all factors that have
eigenvalues greater than the unity, whereas another
method is to examine the scree plot and to retain factors
with eigenvalues in the sharp descent part of the plot
before the eigenvalues start to plateau [30]. A factorial
analysis based on the results of the scree test yields
accurate results more often than the extraction method
based on eigenvalues with values grated than the unity
[30].
In addition, a significant intercorrelation among all
i t e m si nt h eD U Q O La sd e m o n s t r a t e di nT a b l e2c o n -
firms further the sound internal consistency of this
instrument. It has been advocated that “one can achieve
a high internal consistency reliability estimate by having
either many items or highly intercorrelated items (or
some combination of the two)”[31]. In fact, the average
inter-item correlation has been considered “much more
useful index than coefficient alpha per se”.T h em e a n
inter-item correlation score of the DUQOL was 0.491,
which falls within the recommended range of 0.15-0.50
[32].
An interesting highlight of the current study was that
the mean DUQOL scale score was similar to findings
observed in a study conducted in Spain wherein the
Spanish version of the DUQOL was validated [23]. In the
latter study, the correlations between areas and the total
ranged from 0.34 to 0.64. The validation study conducted
in Spain established the criterion validity of the Spanish
version by demonstrating significant correlations, in the
expected directions, with a series of dichotomous vari-
ables. However, a potential weakness of this investigation
was that the Spanish version of the DUQOL was not
compared to another QoL assessment tool. In contrast,
convergent validity in the current study was established
by comparing the DUQOL with the four domains of the
WHOQOL-Bref questionnaire. There were significant
correlations between the DUQOL scores and the scores
of the four domains of the WHOQOL-Brief question-
naire, thereby, suggesting confirmatory evidence that the
DUQOL validly assesses the quality of life of substance
users in this sample.
Other findings related to the DUQOL indicated that
this instrument was easy to administer, well accepted by
most of the research participants and that the majority of
the sample found it easy to complete the questionnaire.
The latter claim is further substantiated by the reduced
mean amount of time needed to complete the test. As
observed elsewhere, questionnaires that investigate health
status and quality of life in multiple domains and with a
larger number of questions tend to take longer to com-
plete [33,34]. Methodologically, the acceptability of an
instrument within a target population is an important
element to take into account when considering the wide-
spread use of a tool. This is especially important as many
surveys use QoL assessment tools in conjunction with
other assessment tools and forms.
Given that validation studies can potentially be more
prone to methodological limitations when conducted over
the telephone [35], a distinct advantage of the current
study was the use of face-to-face interview technique. An
Zubaran et al. Health and Quality of Life Outcomes 2012, 10:31
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recruitment setting. The study was conducted entirely
within the public health care system, which allowed for
the inclusion of all prospective research participants, irre-
spective of private health care insurance cover or employ-
ment status. Therefore, the results presented here provide
a representative analysis of the quality of life of substance
users in urban areas of Australia. Conversely, considering
that environmental factors are known to influence sub-
stance use and mental health in Australia, via circum-
stances like droughts, fires, and limited access to health
care facilities due to remoteness and isolation [36], the fact
that samples were recruited exclusively from urban health
care facilities may be considered as possible limitation in
the present study.
Conclusion
This study demonstrates that the DUQOL and the WHO-
QOL-Bref, which are conceptually designed tools to assess
quality of life, present significant constructural correlations
and are therefore congruent. The internal consistency of
the DUQOL was satisfactory, which demonstrates that the
instrument coherently investigates the quality of life as
measured uniformly by its items. The DUQOL was well
accepted by all volunteers. They answered the questions
without experiencing significant difficulties, which demon-
strates the ease of use of the instrument. The results pre-
sented here indicate that the DUQOL scale represents a
reliable and valid measurement tool for the assessment of
QoL among substance users in Australia.
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